Mapping FACT-P to EQ-5D in a large cross-sectional study of metastatic castration-resistant prostate cancer patients

Por Diels, J., Hamberg, P., Ford, D., Price, P. Wheatley, Spencer, M., Dass, R. N.
Publicado no Qual Life Res (2014)

Decreased exposure to sunitinib due to concomitant administration of ifosfamide: results of a phase I and pharmacokinetic study on the combination of sunitinib and ifosfamide in pa...

Por Hamberg, P, Steeghs, N, Loos, W J, van de Biessen, D, den Hollander, M, Tascilar, M, Verweij, J, Gelderblom, H, Sleijfer, S
Publicado em 2010

Influence of OATP1B1 Function on the Disposition of Sorafenib‐β‐D‐Glucuronide

Por Bins, S, van Doorn, L, Phelps, MA, Gibson, AA, Hu, S, Li, L, Vasilyeva, A, Du, G, Hamberg, P, Eskens, FALM, de Bruijn, P, Sparreboom, A, Mathijssen, RHJ, Baker, SD
Publicado no Clin Transl Sci (2017)

Pazopanib exposure decreases as a result of an ifosfamide-dependent drug–drug interaction: results of a phase I study

Por Hamberg, P, Boers-Sonderen, M J, van der Graaf, W T A, de Bruijn, P, Suttle, A B, Eskens, F A L M, Verweij, J, van Herpen, C M L, Sleijfer, S
Publicado em 2014

Feasibility and effectiveness of trifluridine/tipiracil in metastatic colorectal cancer: real-life data from The Netherlands

Por Kwakman, Johannes J. M., Vink, G., Vestjens, J. H., Beerepoot, L. V., de Groot, J. W., Jansen, R. L., Opdam, F. L., Boot, H., Creemers, G. J., van Rooijen, J. M., Los, M., Vulink, A. J. E., Schut, H., van Meerten, E., Baars, A., Hamberg, P., Kapiteijn, E., Sommeijer, D. W., Punt, C. J. A., Koopman, M.
Publicado no Int J Clin Oncol (2017)